These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6300478)

  • 1. Amiodarone phenocopy of Fabry's keratopathy.
    Whitley CB; Tsai MY; Heger JJ; Prystowsky EN; Zipes DP
    JAMA; 1983 Apr 22-29; 249(16):2177-8. PubMed ID: 6300478
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biochemical studies in Fabry's disease (author's transl)].
    Handa S
    Nihon Jinzo Gakkai Shi; 1978 Nov; 20(11):1212-4. PubMed ID: 219278
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular pathology of Fabry's disease. Physical and kinetic properties of alpha-galactosidase A in cultured human endothelial cells.
    Johnson DL; Desnick RJ
    Biochim Biophys Acta; 1978 Jan; 538(2):195-204. PubMed ID: 23178
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibroblast alpha-galactosidase A activity for identification of Fabry's disease heterozygotes.
    Fensom AH; Benson PF; Grant AR; Jacobs L
    J Inherit Metab Dis; 1980; 2(1):9-12. PubMed ID: 6273649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone keratopathy.
    Fraunfelder FT; Meyer SM
    Trans Ophthalmol Soc N Z; 1984; 36():33-4. PubMed ID: 6591610
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationship of the multiple forms of human alpha-D-galactosidase and alpha-D-fucosidase in the normal and in Fabry's disease.
    Beyer E; Schono N; Kozlova I; Wiederschain G
    Biochim Biophys Acta; 1990 May; 1038(3):386-9. PubMed ID: 2160280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential assay for lysosomal alpha-galactosidases in human tissues and its application to Fabry's disease.
    Mayes JS; Scheerer JB; Sifers RN; Donaldson ML
    Clin Chim Acta; 1981 May; 112(2):247-51. PubMed ID: 6263521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of electron-dense lamellar material from Fabry's disease fibroblasts after enzyme replacement.
    Sifers RN; Mayes JS; Nordquist RE
    Hum Genet; 1983; 65(1):85-7. PubMed ID: 6315565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amiodarone keratopathy and lens opacities.
    Dolan BJ; Flach AJ; Peterson JS
    J Am Optom Assoc; 1985 Jun; 56(6):468-70. PubMed ID: 4008856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience and grading of amiodarone keratopathy.
    Orlando RG; Dangel ME; Schaal SF
    Ophthalmology; 1984 Oct; 91(10):1184-7. PubMed ID: 6514284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabry's disease: biochemical and histochemical studies on hair roots for carrier detection.
    Vermorken AJ; Weterings PJ; Spierenburg GT; vanBennekom CA; Wirtz P; deBruyn CH; Oei TL
    Br J Dermatol; 1978 Feb; 98(2):191-6. PubMed ID: 204324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cornea verticillata - a clinical marker of Fabry disease: case report].
    Cordeiro CA; Oréfice F; Lasmar EP; Santos HH; Valadares ER
    Arq Bras Oftalmol; 2007; 70(4):701-5. PubMed ID: 17906770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biochemical and pathological studies on a carrier of Fabry's disease manifesting bouts of pain in the extremities].
    Katayama M; Kobayashi T; Ohnishi A; Goto I; Kuroiwa Y
    Rinsho Shinkeigaku; 1984 Jun; 24(6):575-80. PubMed ID: 6094070
    [No Abstract]   [Full Text] [Related]  

  • 14. [Substrate specificity of multiple forms of human alpha-D-galactosidase and alpha-D-fucosidase].
    Baskaeva EM; Shono NI; Kozlova IK; Vidershaĭn GIa
    Biokhimiia; 1989 Mar; 54(3):421-6. PubMed ID: 2546612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fate of internalized alpha-2-macroglobulin: alpha-galactosidase conjugate in fibroblasts from Fabry's hemizygote.
    Osada T; Kuroda Y; Ikai A
    Biochem Biophys Res Commun; 1987 Mar; 143(3):954-8. PubMed ID: 2436620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Fabry's disease carriers by enzyme assay of hair roots.
    Hatton CE; Cooper A; Sardharwalla IB
    J Inherit Metab Dis; 1989; 12 Suppl 2():369-71. PubMed ID: 2556612
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of Fabry's disease heterozygotes by hair root analysis.
    Beaudet AL; Caskey CT
    Clin Genet; 1978 Mar; 13(3):251-8. PubMed ID: 205381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual activity of alpha-galactosidase A in Fabry's disease.
    Romeo G; D'Urso M; Pisacane A; Blum E; De Falco A; Ruffilli A
    Biochem Genet; 1975 Oct; 13(9-10):615-28. PubMed ID: 812485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of immobilized fig alpha-galactosidase and effect on ceramide-3 content of plasma from patients with Fabry's disease.
    Schram AW; Hamers MN; Oldenbroek-Haverkamp E; Strijland A; de Jonge A; van den Bergh FA; Tager JM
    Biochim Biophys Acta; 1978 Dec; 527(2):456-64. PubMed ID: 31916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amiodarone-induced cornea verticillata.
    Chew E; Ghosh M; McCulloch C
    Can J Ophthalmol; 1982 Jun; 17(3):96-9. PubMed ID: 7116220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.